MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a special diet and walking slow down a silent blood disorder?
Disease control Not yet recruitingThis small pilot study is testing whether a 12-week Korean-style Mediterranean diet, combined with tracking daily steps, is a practical lifestyle approach for people with early-stage blood cell conditions (MGUS or smoldering myeloma). Researchers want to see if this diet and acti…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Massive study launches to unravel mystery link between blood and immune system
Knowledge-focused Not yet recruitingThis study aims to understand how disorders in blood cell production are connected to various inflammatory and autoimmune diseases. Researchers will observe 5,000 adult patients who have these conditions, collecting their health information over time. The goal is to create a deta…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC